Completed NA INTERVENTIONAL 2-arm NCT02428998

Safety for 24 Weeks Intake of Korean Red Ginseng in Adults

Safety Evaluation for 24 Weeks Intake of Korean Red Ginseng in Adults: A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center, Exploratory Trial

Sponsor: Korea Ginseng Corporation

Conditions Diabetes Healthy Hyperlipidemia Hypertension

Interventions Korean Red Ginseng Placebo

Updated 7 times since 2017 Last updated: Aug 9, 2017 Started: Sep 30, 2014 Primary completion: Aug 31, 2016 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Diabetes and Healthy and is currently completed. Korea Ginseng Corporation leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Sep 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2017 — Sep 2017 [monthly]

Active Not Recruiting NA

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Korea Ginseng Corporation

Data source: Korea Ginseng Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea